13F-HR 1 w75295be13fvhr.txt FORM 13F-HR UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for Calendar Year or Quarter Ended: June 30, 2009 Check here if Amendment [ ]; Amendment Number: ________ This Amendment (Check only one.): [ ] is a restatement. [ ] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: BB Biotech AG Address: Vordergasse 3 Schaffhausen Switzerland CH-8200 Form 13F File Number: 28-6964 The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables are considered integral parts of this form. Person Signing this Report on Behalf of Reporting Manager: Name: Pascal Schmucki Title: SIGNING AUTHORITY Phone: 41 (44) 267 67 00 Signature, Place, and Date of Signing: /s/ Pascal Schmucki ----------------------------------------- Schaffhausen, Switzerland, August 7, 2009 Report Type (Check only one.): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) 1 Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 3 Form 13F Information Table Entry Total: 13 Form 13F Information Table Value Total: $791,002 (thousands)
List of Other Included Managers: Provide a numbered list of the name(s) and Form 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report.
No. Form 13F File Number Name --- -------------------- ------------------- 1 28-11193 Biotech Focus N.V. 2 28-11191 Biotech Invest N.V. 3 28-11189 Biotech Target N.V.
2 BB BIOTECH AG FORM 13F INFORMATION TABLE
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 --------------------- -------- --------- -------- ------------------ ---------- -------- ---------------------- VOTING AUTHORITY TITLE OF VALUE SHS OR SH/ PUT/ INVESTMENT OTHER ---------------------- NAME OF ISSUER CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE -------------- -------- --------- -------- --------- --- ---- ---------- -------- --------- ------ ----- Affymetrix Inc COM 00826T108 11,860 2,000,000 SH DEFINED 1 2,000,000 NONE NONE Arena Pharmaceuticals Inc COM 040047102 24,611 4,931,980 SH DEFINED 3 4,931,980 NONE NONE Biogen Idec Inc COM 09062X103 33,041 731,800 SH DEFINED 1 731,800 NONE NONE Celgene Corp COM 151020104 208,795 4,364,439 SH DEFINED 2 4,364,439 NONE NONE Elan Corp ADR 284131208 9,555 1,500,000 SH DEFINED 2 1,500,000 NONE NONE Gilead Sciences Inc COM 375558103 281,209 6,003,618 SH DEFINED 1 6,003,618 NONE NONE Incyte Corp COM 45337C102 3,116 947,166 SH DEFINED 3 947,166 NONE NONE Keryx Biopharmaceuticals Inc COM 492515101 845 939,311 SH DEFINED 3 939,311 NONE NONE Medicines Co COM 584688105 3,248 387,100 SH DEFINED 3 387,100 NONE NONE Optimer Pharmaceuticals Inc COM 68401H104 14,204 948,839 SH DEFINED 3 948,839 NONE NONE Rigel Pharmaceuticals Inc COM NEW 766559603 2,060 170,000 SH DEFINED 3 170,000 NONE NONE Vertex Pharmaceuticals Inc COM 92532F100 170,858 4,750,000 SH DEFINED 3 4,750,000 NONE NONE Zymogenetics Inc COM 98985T109 27,600 6,000,000 SH DEFINED 3 6,000,000 NONE NONE
3